Publications - Page 33 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Fibrose pulmonaire - FPI 02/08/23
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network.

Lancet Respir Med. 2021 Sep 7: S2213-2600(21)00354-4.
Fibrose pulmonaire - FPI 02/08/23
IC4 : a new combined predictive index of mortality in idiopathic pulmonary fibrosis

Zinellu A, Collu C, Zinellu E, Ahmad K, Nasser M, Traclet J, Sotgiu E, Mellino S, Mangoni AA, Carru C, Pirina P, Cottin V, Fois AG.

Panminerva Med. 2021 Jan 26.
Hypertension pulmonaire (HTP) 02/08/23
Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy

Lechartier B, Berrebeh N, Huertas A, Humbert M, Guignabert C, Tu L.

Chest. 2022 Jan;161(1):219-231.
Fibrose pulmonaire - FPI 02/08/23
NADPH oxidase DUOX1 sustains TGF-β1 signalling and promotes lung fibrosis

Louzada RA, Corre R, Ameziane El Hassani R, Meziani L, Jaillet M, Cazes A, Crestani B, Deutsch E, Dupuy C.

Eur Respir J. 2021 Jan 14;57(1):1901949.
Hypertension pulmonaire (HTP) 02/08/23
Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension

Gazengel P, Hascoët S, Amsallem M, Savale L, Montani D, Mercier O, Humbert M, Fadel E, Le Pavec J.

Eur Respir J. 2022 Jan 20;59(1):2102388.
Hypertension pulmonaire (HTP) 02/08/23
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

Kariotis S, Jammeh E, Swietlik EM, Pickworth JA, Rhodes CJ, Otero P, Wharton J, Iremonger J, Dunning MJ, Pandya D, Mascarenhas TS, Errington N, Thompson AAR, Romanoski CE, Rischard F, Garcia JGN, Yuan JX, An TS, Desai AA, Coghlan G, Lordan J, Corris PA, Howard LS, Condliffe R, Kiely DG, Church C, Pepke-Zaba J, Toshner M, Wort S, Gräf S, Morrell NW, Wilkins MR, Lawrie A, Wang D; UK National PAH Cohort Study Consortium.

Nat Commun. 2021 Dec 7;12(1):7104.
Hypertension pulmonaire (HTP) 02/08/23
Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)

Cottin V, Bensimon L, Raguideau F, Chaize G, Hakmé A, Levy-Bachelot L, Vainchtock A, Dallongeville J, Bouvaist H, Brenot P.

PLoS One. 2021 Dec 7;16(12):e0260483.
Hypertension pulmonaire (HTP) 02/08/23
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

Valentin S, Maurac A, Sitbon O, Beurnier A, Gomez E, Guillaumot A, Textoris L, Fay R, Savale L, Jaïs X, Montani D, Picard F, Mornex JF, Prevot G, Chabot F, Humbert M, Chaouat A.

Eur Respir J. 2021 Nov 4;58(5):2004066.
Hypertension pulmonaire (HTP) 02/08/23
Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension

Masson B, Montani D, Humbert M, Capuano V, Antigny F.

Biomolecules. 2021 Nov 27;11(12):1781.
Hypertension pulmonaire (HTP) 02/08/23
Sex and gender in pulmonary arterial hypertension

Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais MC, Jaïs X, Bertoletti L, Sitbon O, Weatherald J, Humbert M, Montani D.

Eur Respir Rev. 2021 Nov 8;30(162):200330.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

IC4 : a new combined predictive index of mortality in idiopathic pulmonary fibrosis

Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for Therapy

NADPH oxidase DUOX1 sustains TGF-β1 signalling and promotes lung fibrosis

Double-lung transplantation followed by delayed percutaneous repair for atrial septal defect-associated pulmonary arterial hypertension

Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)

Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs

Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension

Sex and gender in pulmonary arterial hypertension